Vanguard Group Inc Arbutus Biopharma Corp Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Vanguard Group Inc holds 8,991,082 shares of ABUS stock, worth $40.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,991,082

Previous 9,085,086 1.03%

Holding current value

$40.6 Million

Previous $28.1 Million 45.41%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$3.08 - $4.9 $289,532 - $460,619	-94,004 Reduced 1.03%	8,991,082 $40.8 Million
Q2 2025 Aug 11, 2025	BUY	$2.88 - $3.61 $378,037 - $473,859	131,263 Added 1.47%	9,085,086 $28.1 Million
Q1 2025 May 09, 2025	SELL	$3.06 - $3.59 $82,745 - $97,077	-27,041 Reduced 0.3%	8,953,823 $31.2 Million
Q4 2024 Feb 11, 2025	BUY	$3.18 - $4.2 $198,056 - $261,584	62,282 Added 0.7%	8,980,864 $29.4 Million
Q3 2024 Nov 13, 2024	BUY	$3.12 - $4.56 $5.92 Million - $8.65 Million	1,896,487 Added 27.01%	8,918,582 $34.3 Million
Q2 2024 Aug 13, 2024	BUY	$2.52 - $3.63 $2.61 Million - $3.75 Million	1,034,188 Added 17.27%	7,022,095 $21.7 Million
Q1 2024 May 10, 2024	SELL	$2.26 - $2.92 $2,205 - $2,849	-976 Reduced 0.02%	5,987,907 $15.4 Million
Q4 2023 Feb 14, 2024	BUY	$1.69 - $2.54 $69,055 - $103,786	40,861 Added 0.69%	5,988,883 $15 Million
Q3 2023 Nov 14, 2023	BUY	$1.9 - $2.27 $244,469 - $292,076	128,668 Added 2.21%	5,948,022 $12.1 Million
Q2 2023 Aug 14, 2023	BUY	$2.24 - $3.06 $399,060 - $545,145	178,152 Added 3.16%	5,819,354 $13.4 Million
Q1 2023 May 15, 2023	BUY	$2.23 - $3.1 $615,874 - $856,148	276,177 Added 5.15%	5,641,202 $17.1 Million
Q4 2022 Feb 10, 2023	BUY	$1.91 - $2.85 $189,359 - $282,551	99,141 Added 1.88%	5,365,025 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $121,231 - $185,716	64,485 Added 1.24%	5,265,884 $10.1 Million
Q2 2022 Aug 12, 2022	BUY	$1.98 - $3.17 $917,177 - $1.47 Million	463,221 Added 9.78%	5,201,399 $14.1 Million
Q1 2022 May 13, 2022	BUY	$2.42 - $3.98 $442,095 - $727,082	182,684 Added 4.01%	4,738,178 $14.1 Million
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $2.46 Million - $3.64 Million	789,515 Added 20.96%	4,555,494 $17.7 Million
Q3 2021 Nov 12, 2021	BUY	$2.65 - $4.62 $78,826 - $137,426	29,746 Added 0.8%	3,765,979 $16.2 Million
Q2 2021 Aug 13, 2021	BUY	$2.5 - $3.51 $9.34 Million - $13.1 Million	3,736,233 New	3,736,233 $11.3 Million

Others Institutions Holding ABUS

# of Institutions

195

Shares Held

118M

Call Options Held

2.67M

Put Options Held

693K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $678M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Arbutus Biopharma Corp Transaction History